Alliance Pharma (LON:APH) Sets New 12-Month High – Time to Buy?

Alliance Pharma plc (LON:APHGet Free Report)’s share price hit a new 52-week high on Wednesday . The stock traded as high as GBX 50.26 ($0.64) and last traded at GBX 48.75 ($0.62), with a volume of 904707 shares. The stock had previously closed at GBX 49.55 ($0.63).

Alliance Pharma Stock Down 0.1 %

The firm has a market capitalization of £260.55 million, a price-to-earnings ratio of -807.50, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The stock has a fifty day moving average of GBX 45.50 and a two-hundred day moving average of GBX 40.67.

Alliance Pharma Company Profile

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Recommended Stories

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.